From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
Xuan Zhao(People's Hospital of Xinjiang Uygur Autonomous Region), Ming Shi(Southwest Jiaotong University), Junnian Zheng(Xuzhou Medical College), Dan Liu(General Hospital of Shenyang Military Region), Xu Wang(Jiangsu University), Zijian Xu(Xuzhou Medical College), Sijin Li(Xuzhou Medical College), Wen Ma(Xuzhou Medical College), Yulin Bao(Xuzhou Medical College), Bi Meng(Xuzhou Medical College), Rui Hou(Xuzhou Medical College)
Cited by 55
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134
CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation
|Cell Death and Differentiation|2014|116